Karlstad O, Starup Linde J, Vestergaard P, et al
Here are the average weight loss results based on the dose and timeline: 1 mg: 7.2% in 24 weeks and 8.7% in 48 weeks 4 mg: 12.9% in 24 weeks and 16.3% in 48 weeks 8 mg: 17.3% in 24 weeks and 23.9% in 48 weeks 12 mg: 17.5% in 24 weeks and 24.2% in 48 weeks Placebo: 1.6% in 24 weeks and 2.1% in 48 weeks The retatrutide clinical trials are still ongoing, with a phase IV planned after the current phase III
Amongst PCOS patients, those who are obese are most at risk of insulin resistance (10)
Our History Founded in 2016 with a clear vision to expand access to reliable compounded medications, ReviveRX was built to serve providers seeking precision, consistency, and greater clinical autonomy
Metabolic and bariatric surgery represents the most effective intervention for severe obesity
Thigh: The outer area of the upper thigh also contains a considerable amount of fat, making it a suitable choice for Wegovy administration